Eisai CEO on Alzheimer's treatment drug trial results

Описание к видео Eisai CEO on Alzheimer's treatment drug trial results

Ivan Cheung, Eisai U.S. chairman and CEO, speaks exclusively with "Power Lunch" and CNBC's Meg Tirrell about the drug trial for an Alzheimer's treatment from Biogen and Eisai.

Комментарии

Информация по комментариям в разработке